Aquestive Therapeutics (AQST) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

2.730
+0.080+3.02%

Close Mar 4 16:00 ET

248.92MMarket Cap-6.01P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Scheduled For March 5, 2025
Benzinga50minutes ago
Aquestive Therapeutics Q4 2024 Earnings Preview
Seeking Alpha17:35 ET
Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $13
Moomoo NewsMar 3 16:32 ET · Ratings
Earnings Preview: AQST to Report Financial Results Post-market on March 05
Moomoo NewsFeb 27 20:00 ET
Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $13
Moomoo NewsFeb 19 17:31 ET · Ratings
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn Into More Strength?
Zacks Feb 13 09:25 ET

Comments

AQST will be presenting at the AAAI 2025 Annual Meeting this weekend re findings on Anaphylm (SL epinephrine) as treatment for anaphylaxis.

$Aquestive Therapeutics (AQST.US)$

6

Venrock Healthcare Capital Partners III 2,629,786 shares, 2.9%
$Aquestive Therapeutics (AQST.US)$
nfa

Aquestive Therapeutics | SCHEDULE 13G/A: Others

Bratton Douglas K. 10,023,384 shares, 11.1%
$Aquestive Therapeutics (AQST.US)$
nfa

Aquestive Therapeutics | SCHEDULE 13G/A: Others

Dec 25, 2024 10:20

What’s the Top Undervalued BioTech

$Humacyte (HUMA.US)$ $uniQure NV (QURE.US)$ $Aquestive Therapeutics (AQST.US)$ $IDEAYA Biosciences (IDYA.US)$ $Day One Biopharmaceuticals (DAWN.US)$
share your thoughts & ideas explain why 2025 will be amazing several break free and run
apextradez Wins so can you

1

Dec 19, 2024 07:06

$Aquestive Therapeutics (AQST.US)$ bring it on

Read more